(Total Views: 432)
Posted On: 02/03/2020 1:34:49 PM
Post# of 153933
Re: Watching_CYDY #16687
Quote:
The conference call will focus on, amongst other updates, the following key agenda items:
Status of filing the Biologics License Application (BLA) for leronlimab in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients
Update on CytoDyn’s therapeutic indications involving cancer
Update on potential use of leronlimab in China to treat the 2019 Novel Coronavirus (2019-nCov)
Looks like its the first item of discussion
(0)
(0)
